| 发明名称 |
ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS |
| 摘要 |
The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene. |
| 申请公布号 |
US2017014426(A1) |
申请公布日期 |
2017.01.19 |
| 申请号 |
US201615223066 |
申请日期 |
2016.07.29 |
| 申请人 |
LABORATOIRE HRA-PHARMA ;INSERM (Institut National de la Sante et de la Recherche Medicale) |
发明人 |
RESCHE-RIGON Michele;LEVY Delphine;GAINER Erin;GOMPEL Anne;FORGEZ Patricia;DESREUMAUX-COMMUNAL Laudine |
| 分类号 |
A61K31/57;A61K9/00 |
主分类号 |
A61K31/57 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for providing regular contraception in a woman at risk of developing a breast cancer comprising administering ulipristal acetate or a metabolite thereof to the woman. |
| 地址 |
Paris FR |
